Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Benzodiazepines

Are Benzodiazepines legal in Slovenia?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Controlled in Slovenia member by member, and Slovenia’s own annex names the members, so this is a finding rather than a deferral. The member by member check was run against the Slovenian schedule and not merely against the substances this table happens to carry: the annex to the Uredba o razvrstitvi prepovedanih drog prints alprazolam, diazepam, klonazepam, lorazepam and nimetazepam as separate entries in Group III, the benzodiazepine anxiolytics and hypnotics subsection, row 18, each with its own chemical name beside it, and each of those five printed names carries the benzodiazepine ring in the text of the entry itself. The printed chemical name is what settles membership here rather than the popular grouping. The annex also carries a compound that is commonly counted with this class and whose own printed name is a thieno triazolo diazepine, with thiophene standing where the benzene ring would be, and that compound is controlled on its own separate Group III entry rather than as a member of this one. The family word itself is not an annex entry, so what is controlled is each named member and not the word, and a compound that shares part of the ring system without appearing in the annex is not reached by the family name alone. Article 2 of the Uredba makes the annex a constituent part of the regulation. The annex was read on 20 September 2026 and this does not rule out a later amendment.
Consequences if caught
Capital exposure: none. Slovenia has abolished the death penalty and no Slovenian drug offence carries one, so this is a settled country level fact and not a reading of where any substance sits on the list. The exposure that does attach runs on three provisions. Personal use is handled under article 33 of the Production of and Trade in Illicit Drugs Act, the ZPPPD, which treats a smaller quantity held for one time personal use as a minor offence and carries a fine of roughly 42 to 209 euro, reduced or remitted where the person enters approved treatment. That article states no gram figure at all and it is a lighter route rather than a lawful possession allowance. Trafficking and manufacture fall under article 186 of the Criminal Code, the KZ-1, at one to ten years, rising to three to fifteen years on the aggravated limbs for organised conduct or conduct involving minors or vulnerable persons, and fifteen years under article 186, paragraphs 2 and 3, is the drug offence ceiling in Slovenian law. Facilitating consumption falls under article 187 at six months to twelve years. For this class the three provisions apply through whichever named member is actually in hand, so the answer turns on identifying the compound and then reading its own entry.
If prescribed or medical
The source read for this cell carries no prescription column, so no substance specific Slovenian medical route is stated here and none is assumed. The country level traveller rule is the one the source does state: Groups II and III of the annex can include medicines, and lawful travel still turns on the applicable prescription, the original dispensing packaging and any Schengen or Slovenian certificate that is required, with a foreign brand assessed through its proved active ingredients rather than its name. The members the annex names sit in Group III, one of the two groups the source identifies as capable of carrying medicines, but the source states no route for any of them, so the route is deferred here rather than stated.
Documentation
Carry any controlled medicine in its original dispensing packaging with the prescription, and carry a Schengen certificate where one is required for the substance and the length of stay. Confirm the requirement with the Slovenian embassy or consulate before travelling rather than at the border, and be ready to show the active ingredient, since a foreign brand name is assessed in Slovenia through its proved ingredients and not through the name on the box. For this row the finding rests on named members in Group III, and those entries were read on 20 September 2026. The annex to the Uredba o razvrstitvi prepovedanih drog was read on 20 September 2026. The dossier read for this cell names no edition and no amendment date for that annex, so the horizon of this cell is the reading date and nothing later, and this does not rule out a later amendment. The list moves by amendment of the Uredba itself, because article 2 of the Uredba makes the annex a constituent part of the regulation, so the Criminal Code can stay untouched while the names on the list change.
Primary sources
  • Slovenia, Uredba o razvrstitvi prepovedanih drog, article 2 and the annex in Groups I, II and III
  • read at https://pisrs.si/pregledPredpisa?id=URED7970 with the annex at https://pisrs.si/api/datoteke/integracije/403462486 on 20 September 2026. For this row the members relied on are the Group III entries for alprazolam, diazepam, klonazepam, lorazepam and nimetazepam. The Production of and Trade in Illicit Drugs Act, the ZPPPD, article 33, at https://pisrs.si/pregledPredpisa?id=ZAKO1388
  • the Criminal Code, the KZ-1, articles 186 and 187, at https://pisrs.si/pregledPredpisa?id=ZAKO5050. Annex entry headings are printed in capitals in the original and are re-voiced here in normal case. The fifteen year ceiling at article 186, paragraphs 2 and 3, and the absence of any death penalty, are stated by the dossier read for this cell. The fine band of roughly 42 to 209 euro under article 33, the one to ten and three to fifteen year ranges under article 186 and the six months to twelve years under article 187 are carried forward from the Slovenia entry already published and were not re-derived from the statute text in this pass
  • they do not contradict the ceiling the dossier states. The register publishes the Uredba, its annex, the Act and the Criminal Code for public reading, which is not an unrestricted licence to republish, so only the wording needed for verification is reproduced. No judicial ruling is relied on, and product composition, structural identity, medicinal authorisation and intent all remain fact sensitive. The dossier names no edition or amendment date for the annex, and this does not rule out a later amendment.
  • the group stated for this row was confirmed against the annex itself, read at the Slovenian legal information system on 21 September 2026: the entry printed as KLONAZEPAM stands under the heading SKUPINA III, subsection b.1.0 at its row 18. The group is a heading above the rows rather than a column on them, which is why no quotation of a single row can carry it, and this reading supersedes the earlier statement that the group rests on a locator column alone
  • SKUPINA III is divided into subsections whose row numbers restart in each, so a row number alone does not identify an entry there. This row is in subsection b.1.0. Row 18 of b.1.0 is KLONAZEPAM and row 18 of c.1.0 is FENIBUT, which is why those two were earlier reported as colliding on one number when both locators were correct

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Slovenia